Firm Management
AstraZeneca Fails Lung Cancer Drug Trial, Dragging Its Shares to 5%
AstraZeneca’s shares fell over 5% following disappointing results from its TROPION-Lung01 Phase III trial, which showed its experimental lung cancer drug did not improve survival rates.
Boeing Reaches Deal With Union, Avoiding Potential Strike and Increasing Shares by 3%
Boeing's shares rose 3% in premarket trading after a tentative labor agreement with a Pacific Northwest union, which includes a 25% wage increase and a commitment to build future aircraft in Seattle, potentially averting a major strike.
Venture Capital Firm, Atomico, Raises $1.24B to Help European Startup Companies Grow—How Will They Benefit?
Atomico has raised $1.24 billion across two new funds to support both early-stage and growth-stage startups in Europe, causing renewed confidence in the region's tech sector.
Ford and Other Top Companies Pull Back From DEI Initiatives—Here's Why It's Bad for Business
Anti-DEI activism pushes major companies like Ford and Molson Coors to scale back their diversity efforts, risking brand reputation and investor confidence.